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Background: In the last few years, transcranial direct current stimulation (tDCS) has
emerged as an appealing therapeutic option to improve brain functions. Promising data
support the role of prefrontal tDCS in augmenting cognitive performance and ameliorating
several neuropsychiatric symptoms, namely pain, fatigue, mood disturbances, and
attentional impairment. Such symptoms are commonly encountered in patients with
multiple sclerosis (MS).
Objective: The main objective of the current work was to evaluate the tDCS effects
over the left dorsolateral prefrontal cortex (DLPFC) on pain in MS patients.Our secondary
outcomes were to study its influence on attention, fatigue, and mood.
Materials and Methods: Sixteen MS patients with chronic neuropathic pain were
enrolled in a randomized, sham-controlled, and cross-over study.Patients randomly
received two anodal tDCS blocks (active or sham), each consisting of three consecutive
daily tDCS sessions, and held apart by 3 weeks. Evaluations took place before and
after each block. To evaluate pain, we used the Brief Pain Inventory (BPI) and the Visual
Analog Scale (VAS). Attention was assessed using neurophysiological parameters and
the Attention Network Test (ANT). Changes in mood and fatigue were measured using
various scales.
Results: Compared to sham, active tDCS yielded significant analgesic effects according
to VAS and BPI global scales.There were no effects of any block on mood, fatigue, or
attention.
Conclusion: Based on our results, anodal tDCS over the left DLPFC appears to act in a
selective manner and would ameliorate specific symptoms, particularly neuropathic pain.
Analgesia might have occurred through the modulation of the emotional pain network.
Attention, mood, and fatigue were not improved in this work. This could be partly
attributed to the short protocol duration, the small sample size, and the heterogeneity of
our MS cohort. Future large-scale studies can benefit from comparing the tDCS effects
over different cortical sites, changing the stimulation montage, prolonging the duration of
protocol, and coupling tDCS with neuroimaging techniques for a better understanding
of its possible mechanism of action.
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INTRODUCTION
Multiple sclerosis (MS) is a chronic progressive inflammatory
disease of the central nervous system, and represents the major
cause of non-traumatic disability in young adults (Noseworthy
et al., 2000; Compston and Coles, 2008). During the course of
the disease, the patients may develop sensorimotor, cognitive,
emotional, and behavioral symptoms. For instance, although
MS was previously considered a painless disease, chronic pain
has been recently reported as a debilitating symptom (Ehde
et al., 2005), with a prevalence varying between 29 and 86%
(O’Connor et al., 2008). The lower limbs dysesthesias remain
the most common and difficult to treat painful symptoms,
attributed to demyelination and axonal degeneration processes
involving the central sensory pathways (O’Connor et al., 2008).
Psychiatric comorbidities are also common (Marrie et al., 2015).
In particular, anxiety and depression were found to occur in
about 21.9 and 23.7% of MS patients, respectively (Marrie et al.,
2015). Moreover, up to 75% of MS patients can face fatigue at
some point during the disease course; such a symptom was found
to have a drastic impact on their quality of life (Chalah et al.,
2015). Furthermore, abnormalities in the attentional capacities
have been described in MS patients (Urbanek et al., 2010; Crivelli
et al., 2012; Omisade et al., 2012; Vázquez-Marrufo et al., 2014;
Ayache et al., 2015).
The interaction between pain and attention has gained an
increasing interest in the last decade. Although pain serves
as a warning signal for responding to potential hazards, its
relationship with the intensity of a stimulus is not linear. It
is rather modulated by several factors, among which attention
appears to play a major role (Van Damme et al., 2010). On
the one hand, distraction was documented to decrease the
perceived intensity of provoked pain (Legrain et al., 2002). On
the other hand, pain can capture the attentional processes, in a
way that prohibits good performance on cognitive tasks, even
with a voluntary neglect of the nociceptive stimuli (Eccleston
and Crombez, 1999; Legrain et al., 2009a,b; Van Damme et al.,
2010). In this perspective, the neurocognitive model of attention
to pain explains the aforementioned interaction by two modes
of selection: the top-down attention, which prioritizes relevant
information and prevents irrelevant stimuli such as pain from
capturing attention, and the bottom-up attention by which
unintentional stimulus captures the attention (Legrain et al.,
2009a).
The current advances in neuroimaging and
neurophysiological modalities have unveiled the key role of
the dorsolateral prefrontal cortex (DLPFC) in the circuits of pain
(Lorenz et al., 2003), fatigue (Chalah et al., 2015), depression
(Gobbi et al., 2014), and attention (Petersen and Posner, 2012),
including the attentional circuit dedicated to noxious stimuli
(Legrain et al., 2009a). Among the available literature regarding
experimental pain, one study has revealed negative correlations
between the activation patterns within the DLPFC bilaterally and
each of pain intensity and unpleasantness (Lorenz et al., 2003).
Here, the DLPFC was thought to modulate pain perception
through corticosubcortical and corticocortical pathways. In
addition, DLPFC seems to be a major component of the so-called
cortico-striato-thalamo-cortical fatigue loop in MS (Chalah
et al., 2015). Moreover, the middle frontal gyrus, which embeds
the DLPFC, was found to be selectively related to depression
in MS (Gobbi et al., 2014). Furthermore, DLPFC constitutes
a main component of the attentional circuits, particularly the
fronto-parietal executive control network (Petersen and Posner,
2012). This was based on lesions studies in human where the
DLPFC appears to be involved in switching from one set of
tasks to the other (Petersen and Posner, 2012). Nevertheless,
experimental research investigating the interaction between
bottom-up and top-down attention has highlighted the role of
DLPFC in processing the painful stimuli (Legrain et al., 2009a).
By maintaining the attentional load, this cortical area prioritizes
goal-relevant information in order to prevent the attentional
capture by pain (Legrain et al., 2009a). Therefore, one can
assume that acting on DLPFC might have an impact on pain
perception, attentional resources, mood, and fatigue.
Noninvasive brain stimulation (NIBS) is currently being
investigated for the management of neuropsychiatric symptoms
when pharmacological interventions fail. Among those
techniques, transcranial direct current stimulation (tDCS)
has gained a particular interest in recent years, and appears to
be a promising tool for the treatment of several neurological
disorders. It acts by changing the cortical excitability (Nitsche
and Paulus, 2000, 2001; Nitsche and Fregni, 2007; Nitsche et al.,
2008), notably by depolarizing (activating) and hyperpolarizing
(inhibiting) the cortical circuits, in the case of anodal and
cathodal stimulation, respectively.
In the present work, we applied anodal tDCS over the left
DLPFC. Our primary endpoint was to evaluate its effects on
neuropathic pain in MS patients. Our secondary outcomes were
to assess its impact on attention, mood, and fatigue.
MATERIALS AND METHODS
Ethics Statement
This is a prospective, randomized, cross-over, sham-controlled
study, conducted according to the declaration of Helsinki,
and approved by the local ethical committee (CPP-Ile de
France VI, registered as N◦ 2012-A00721-42). The trial is
registered at the Deutsches Register Klinischer Studien (drks-
neu.uniklinik-freiburg.de) and has the following registration
number: DRKS00005296. All participants were well instructed
about the protocol and voluntarily gave their written informed
consent prior to inclusion.
Study Participants
Patients were enrolled by M.A., M.S., D.D., and A.C. from
the Neurology department of Henri Mondor Hospital, Créteil,
France, between November 2012 and November 2014 according
to the following criteria: (i) a definite MS diagnosis according
to the 2010 revised McDonald criteria (Polman et al., 2011);
(ii) age between 18 and 70 years; (iii) right handedness based
on the Edinburgh inventory (Oldfield, 1971); and (iv) a history
of neuropathic pain since more than 3 months as per the
Neuropathic Pain Symptom Inventory (NPSI; Bouhassira et al.,
2004), with an intensity >40 on the visual analog scale from 0
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to 100 (VAS0−100), obtained as the average of daily scores over a
representative week.
Exclusion criteria consisted of the following: (i) MS relapses
within the last 2 months; (ii) changes in pharmacological and
physical therapies during the last month; (iii) the presence of
comorbid neurodegenerative or psychiatric disorders; (iv) history
of substance abuse; (v) absence of measurable pain related
evoked potentials (PREPs) at the right hand; (vi) severe deficit
in the visual acuity or fields as documented by an ophthalmic
exam; and (vii) severe right upper limb impairment as per
the Medical Research Council scale for muscle power (MRC)
(Medical Research Council, 1981). For the latter, we applied the
MRC score to the four muscle groups involved in pinching,
wrist extension, forearm flexion, and arm abduction, so that the
sum of their scores could vary between 0 (null strength) and 20
(full strength); an MRC score <12 excluded the individual from
participation.
A standard neurological examination was performed in all
patients including a documentation of the disability level based
on the expanded disability status scale (EDSS; Kurtzke, 1983),
and a thorough pain evaluation.
tDCS
A battery driven multi-channel direct current stimulator
(Starstim, Neuroelectrics, Barcelona, Spain) delivered the direct
current over the scalp through sponge electrodes (surface
area = 25 cm2), soaked in a saline solution to minimize the
risk of skin irritation (Palm et al., 2014). The stimulation
electrodes were directly positioned on an adult sized cap worn
by the patients, and labeled according to the 10–20 EEG system
of electrode positioning (Starstim, Neuroelectrics, Barcelona,
Spain). To stimulate the left DLPFC, the anode was placed over
F3, and its corresponding cathode over the right supraorbital
region (Figure 1). The used current intensity was 2 mA (total
current density over the stimulated area: 0.06mA/cm2) which
is below the threshold for tissue damage (Poreisz et al., 2007;
Nitsche et al., 2008). For the active stimulation, the current
was ramped up during the first 15 s to a maximum of 2 mA
that was maintained throughout the 20-min stimulation session.
As for the sham stimulation, the current was ramped down
immediately after ramping up in order to achieve an effective
blinding (Gandiga et al., 2006; Ambrus et al., 2012).
Sham or active anodal tDCS blocks were tested in a
random order and were held apart by at least 3 weeks. Each
block consisted of three consecutive daily tDCS sessions. The
stimulations were performed by well-trained physicians. The
sessions took place in a quiet and illuminated room. The patients
were at rest in an armchair and were not performing any
cognitive task. Only the performing physician (S.S.A) was aware
of the stimulationmode (real or sham tDCS). The evaluators (U.P
and M.A.C) and the patients were blind to it.
Primary Outcomes: Pain Scales
For pain evaluation, we relied on the self-reported VAS0−100 and
the short version of the Brief Pain Inventory (BPI). The latter
is a validated and reliable tool to measure pain intensity and its
interference with patient’s life (Cleeland and Ryan, 1994).
Secondary Outcomes
Cognitive Task
Attention was evaluated using a computerized test: The Attention
Network Test (ANT; Fan et al., 2002). Briefly, this test evaluates
the three main attentional networks: the alerting network that
consists of controlling vigilance and task performance, the
orienting network responsible for the orientation to external
stimuli, and the executive function network in charge of conflict
resolution (Fan et al., 2002; Petersen and Posner, 2012). The
test was performed in a quiet room, with the participants sitting
in front of a monitor aligned to their midsagittal plane. The
stimulus consists of a row of five horizontal black arrows, against
a white background: a “central” arrow surrounded on each
side by two others called “flankers” which can be pointing left-
or right-ward. Several possible conditions arise: a “congruent”
condition takes place when the flankers and the central arrow
are in same direction; an “incongruent” condition occurs when
the flankers and the central arrow are in opposite direction; and a
“neutral” condition occurs when the flankers are replaced instead
by four strokes. The participants indicated the direction of the
central arrow by clicking on the left or right mouse buttons,
with either the right index or the right middle finger, when
the central arrowhead pointed to the left or right, respectively.
During the total duration of the test, the subjects are asked to fix
a central cross, and are informed about a warning “cue,” which
consists of a star-shaped signal that may precede the stimulus
in question, and thus might either help or not in localizing the
latter. Here, four possibilities exist: “no cue” condition when
there is no preceding signal, “center cue” condition when it
appears at the center of the screen, “double cue” condition
when signals are simultaneously provided above and below the
central cross, and a “spatial” cue condition when the signal
is presented either up or down the cross. We used the 1.3.0
version of ANT, which includes one practice sequence (24
trials), and three identical sequences of 96 trials each, separated
by an optional resting period. The participants should answer
correctly as fast as possible, and the test provides the mean
accuracy (MA) and the mean reaction time (MRT), which reflect
the errors rate and the time required by the participant to
answer, respectively. Moreover, all conditions are analyzed to
assess the integrity of the attentional networks. For instance,
the alerting network is evaluated when the participant fixes
the central cross; the orienting network is put into play when
the warning signal is presented prior to the stimulus; and the
executive function network is recruited when the subject is
trying to solve the conflict and takes a decision in order to
answer.
Neuropsychological Assessment
Mood and fatigue were evaluated using the 14-item Hospital
Anxiety and Depression Scale (HADS; Snaith and Zigmond,
1986) and the 21-item Modified Fatigue Impact Scale (MFIS),
respectively (Fatigue guidelines development panel of the
multiple sclerosis council for clinical practice guidelines, 1998;
Téllez et al., 2005). MFIS accounts for the physical (9 items),
cognitive (10 items), and psychosocial (2 items) components of
fatigue.
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FIGURE 1 | An illustration of the tDCS montage in this study (Starstim, Neuroelectrics, Barcelona, Spain); with a cathode over AF8 (A), an anode over
F3 (A,B) according to the international 10–20 EEG system. A simulation of the electric field generated between F3 (in red) and AF8 (in blue) is shown in (C).
Neurophysiological Testing
Pain related evoked potentials (PREPs)
PREPs can be generated at the cortical level by a variety
of noxious stimuli (Kakigi et al., 2005; Arendt-Nielsen and
Andersen, 2006), namely the lasers (Arendt-Nielsen and Chen,
2003). Their amplitudes serve as physiological correlates for the
amount of attention paid toward noxious stimuli, and reflect
the functionality of the involved neural networks (Garcia-Larrea
et al., 2002; Lorenz and Garcia-Larrea, 2003). A concentric planar
electrode—which was previously found to be an alternative to
laser in inducing PREPs—has served the purpose in this work
(Kaube et al., 2000; Lefaucheur et al., 2012).
The first step consisted of defining the pain perception
threshold (PPT). The PPT was determined by the method of
limits, which consists of raising the stimulus intensity from zero
to the point where the stimulus is perceived as painful sensation
at intensity of 60–70 on VAS0−100. The threshold was determined
three times. The average of the three trials was defined as
the PPT.
Stimulation was carried out using a concentric electrode
designed to excite the superficial skin layers, hence the
nociceptive axons (Lefaucheur et al., 2012). Stimuli were applied
at the first dorsal interosseous space of the right hand, the
cutaneous area located on the dorsal and lateral aspect of
the hand between the extensor pollicis longus tendon and the
extensor indicis tendon. A single stimulus was a train of three
pulses that lasts 0.5ms, with an inter-pulse interval (IS) of 5ms.
After determining the PPT, two sets of twenty stimuli were
performed at irregular intervals, at VAS60−70.The PREPs were
recorded via 10mm Genuine Grass Gold Cup Electrodes (Grass
Products, Astro-Med, Inc., Natus Neurology, Warwick, RI 02886
U.S.A.), fixed to the scalp surface using a special paste (Grass
Products, Astro-Med, Inc., Natus Neurology, Warwick, RI 02886
U.S.A.). The electrodes were positioned as the following: the
recording one at Cz (international 10–20 EEG system of electrode
positioning), the reference one at the left earlobe, and the
ground one with a Velcro strap around the right forearm (Ref
NT-S07ALPINE ground electrode with Velcro Strap, Alpine
Biomed, Skovlunde, Denmark). In addition, electro-oculogram
was obtained via pre-gelled adhesive surface electrodes (Ref
9013S0242, Alpine Biomed, Skovlunde, Denmark) placed at the
right infraorbital lateral margin.
The recorded signal was bandpass filtered at 0.5–30Hz and
stored for analysis using a Keypoint machine (Dantec Dynamics,
Bristol, United Kingdom). The final step consisted of averaging
the signals oﬄine, and excluding the contaminated recordings
(saccadic eye movements or blinks, and raw signals above 70V).
We then analyzed the collected N2-P2 responses and measured
their baseline-to-peak amplitudes, peak-to-peak amplitudes, and
latencies.
Frontal midline theta activity
The frontal midline theta (Fm2) is an oscillatory activity in
the theta band (4–7 Hz) that appears in the medial frontal
region at any time during the performance of a cognitive
task, reaching 6–7Hz in frequency and 30–60mV in amplitude
(Ishihara and Yoshi, 1972; Mizuki et al., 1980). We looked
for this activity by recording EEG during the second ANT
sequence. The recording electrodes were located on the patients’
cap at Fpz and Fz (according to the international 10–20 EEG
system of electrode positioning), and connected to the recording
device (Starstim, Neuroelectrics, Barcelona, Spain). The raw EEG
signals were stored for oﬄine processing and analysis. These
signals were then pass-band-filtered in the frequency range [0.5–
30Hz] to keep only the rhythms of interest delta, theta, alpha
and beta.
An important step before doing any analysis would be to
reject ocular and blink artifacts that are highly abundant in raw
data. For this, prior to any analysis, we applied on all data an
algorithm that detects, localizes, and rejects artifacts in a single-
channel biosignal. An example of the artifact rejection is shown
in Figure 2.
EEG analysis
EEG analysis was performed by T.A. and A.B. To obtain
a good estimate of the percentage held by the dominant
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FIGURE 2 | An example of artifact rejection in a single EEG record.
FIGURE 3 | Schematic diagram of the experimental protocol. Two tDCS blocks, each consisting of 3 consecutive daily stimulations of either sham tDCS or
active tDCS (randomized order); held apart by a 3-week interval.ANT, Attention Network Test; BPI, Brief Pain Inventory; CGI, Clinical Global Impression; CRQ, Comfort
Rating Questionnaire; EEG, recording at Fpz and Pz during ANT; EDSS, Expanded Disability Status Scale; HADS, Hospital Anxiety and Depression Scale; MFIS,
Modified Fatigue Impact Scale; NPSI, Neuropathic Pain Symptoms Inventory; PREPs, Pain Related Evoked Potentials; VAS*, Visual Analog Scale for pain assessed 7
days prior to the first stimulation session (D1) and 7 days after the last stimulation session (D3) of each block.
rhythms (delta, theta, alpha, and beta) in a given raw EEG
signals we determined the frequencies that dominate each
signal.
First, the signals were band-pass filtered in the frequency
bands [0.5–3.5Hz], [4–7Hz], [8–12Hz], and [13–30Hz]
corresponding to the rhythms delta, theta, alpha, and
beta respectively. To take into account the difference
in the amplitudes of these rhythms, we determined the
gradient of their amplitudes, looked for their envelopes,
and calculated the modulus of the Hilbert transform of
the gradients in question (Marple, 1999). At each sample
of the given EEG signal, we selected the maximum
modulus. Finally, the percentage of each frequency
band in the given EEG signal of each patient was
determined.
Experimental Protocol
After the inclusion session, patients were randomized to receive
either sham or active tDCS block (Figure 3). The randomization
schedule was generated by U.P. prior to the beginning of
the study using a dedicated software (“true” random number
generation without any restriction, stored in a computer until the
patient was assigned to the intervention).
Keeping in mind the fluctuating nature of neuropathic pain,
and the effects of circadian rhythm on attentional capacities, the
patients underwent the experimental protocol at the same time
of the day (Knight and Mather, 2013). They were also asked to
restrict stimulants consumption, like caffeine or nicotine, at least
3 h prior to their appointment. No blocks were performed during
summer time to avoid any influence of temperature on fatigue
(Chalah et al., 2015).
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FIGURE 4 | Schematic flow chart of patients through the study.
The patients daily recorded the average of their pain intensity
1 week before and 1 week after each block using VAS0−100. At the
first day of each block (D1), they were asked to fill questionnaires
for pain (BPI), fatigue (MFIS), anxiety and depression (HADS).
This was followed by PREPs recording, the performance of ANT
test, and finally the tDCS session. The latter was repeated at the
second (D2) and third (D3) day of each block. At D3, the above-
mentioned evaluations were repeated following the stimulation
session, and the patients’ degree of satisfaction regarding the
protocol was assessed using the Comfort Rating Questionnaire
(CRQ) and the Global Clinical Impression (GCI). At the end
of each block, the patients were asked to guess the mode of
stimulation (active/sham). A schematic diagram is shown in
Figure 3.
Data Analysis
For the ANT parameters, we excluded from the analysis the
reaction times of trials with either error or with a reaction time
value above or below the mean ± 2 standard deviations (SD).
Statistical analyses were performed using the StatView and InStat
software. Our Data followed normal distributions according to
the method of Kolmogorov and Smirnov. Data collected before
and after each block were analyzed with paired t-tests, and those
with a p< 0.05 were considered significant. This included PREPs
(amplitudes and latencies), ANT parameters (MA and RT),
frontal theta activity percentages, and self-rating questionnaires
scores for pain (VAS0−100, BPI), fatigue (MFIS), anxiety and
depression (HADS).
RESULTS
Demographic and Clinical Data
Twenty MS patients were enrolled, and four were excluded
(one declined to participate, and three were not eligible).
Sixteen patients (13 women, 3 men, mean age 48.9 ±
10.0 years, age range 38–67 years) completed the study
(Figure 4 illustrates the flowchart of all participants). All
had neuropathic pain; their mean NPSI was 5.12 ± 2.4
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at enrollment. Their mean EDSS was 4.25 ± 1.4. Eleven
patients had relapsing remitting MS (RRMS), four were in the
secondary progressive phase (SPMS) and one had a primary
progressive type (PPMS). The mean disease duration was
11.8 ± 9.4 years and the progressive phase duration was 6 ± 3.2
years.
All patients had concomitant medication intake, consisting
of antiepileptic drugs (nine patients; one of them with two
drugs), antidepressants (nine patients, one of them with two
drugs), opioids (five patients, one of them with two drugs)
and immunomodulating agents (13 patients). Pharmacological
treatment was continued and kept stable throughout the
experimental protocol.
Adverse Effects, Comfort Rating, and
Blinding Integrity
After both active and sham stimulation, six patients reported
insomnia. Nausea was reported by five patients after active
stimulation and by four patients after sham stimulation. Severe
headache occurred in three patients after active stimulation and
in one patient after sham stimulation. Phosphenes were reported
by one patient after sham stimulation.
No significant difference was found between both conditions
regarding the CRQ sum scores during (p = 0.96) and after
stimulation (p = 0.43). No significant differences were observed
between both stimulation conditions on the overall discomfort
(p= 0.79) or the mean GCI (p= 0.82; Friedman test). Details are
provided in Table 1.
Pain Perception
The mean VAS0−100 pain ratings 7 days before and 7 days
after stimulation showed significant decrease after active tDCS
(p = 0.024), but no change after sham tDCS (p = 0.66).
Analogously, the mean VAS0−100 pain ratings for days 1–3
before and after stimulation showed significant decrease after
active tDCS (p = 0.021), and no improvement after sham tDCS
(p= 0.56).
Active stimulation resulted in a significant improvement of
BPI global score (p = 0.02), and its interference subscale (p =
0.01), but had no significant effects on the severity subscale. Sham
did not have any significant effects on BPI scores or its subscales.
Pain scores are found in Table 2.
Cognitive Results
There were no significant changes in any of the ANT parameters
after both sham and active stimulation (Table 3).
Neuropsychological Scores
The baseline mean global MFIS score, HADS anxiety and
depression subscales were 52.6 ± 12.2, 9.2 ± 4.0, and 6.6 ± 3.2,
respectively.
No significant differences were observed following both
stimulation conditions for the MFIS total scores, HADS total
scores and subscales. The neuropsychological scores are detailed
in Table 4.
TABLE 1 | Confort rating questionnaire (CRQ) and global clinical
impression (GCI) for sham and active tDCS.
Sham tDCS paired t-test
CRQ sum scores
during stimulation
18.3 ± 12.3 19.1 ± 11.5 P = 0.96
CRQ sum scores after
stimulation
20.7 ± 13.8 17.5 ± 9.6 P = 0.43
Overall discomfort after
stimulation
2.4 ± 2.0 2.6 ± 2.3 P = 0.79
Mean GCI after
stimulation
4.6 ± 0.8 4.6 ± 0.9 P = 0.82
Neurophysiological Testing
PREPs
PREPs results did not significantly differ between active and sham
stimulation (Table 5).
EEG Results
A trendwise or significant increase in the theta bandwas observed
following sham and active stimulation, respectively. Theta Fpz
showed a trendwise increase after sham stimulation (p = 0.09),
and theta Fz showed significant increase after sham stimulation
(p = 0.04). After active stimulation, theta Fpz and Fz increased
by trend (p= 0.09 and p= 0.09, respectively; Table 5).
DISCUSSION
This study aimed to explore the impact of prefrontal tDCS on
pain in 16MS patients. Active anodal but not sham tDCS showed
significant analgesic effects on VAS0−100 pain ratings in the first 3
days and over 1 week after stimulation. These effects were further
reflected by a significant decrease in the BPI total score and
its interference subscale following only active stimulation. No
relevant changes in BPI severity subscale were found after either
stimulation conditions. Similarly, neither intervention had any
effects on PREPs (amplitudes and latencies), ANT parameters,
fatigue and mood scales. Lastly, a trendwise or a significant
increase in the frontal theta activity was observed following active
or sham stimulation, respectively.
Effects on Pain
The most prominent effect of tDCS treatment was analgesia.
Such findings are of high interest and in line with previous
studies. In fact, the DLPFC is known to have a crucial role in
modulating pain (Lorenz et al., 2003). Interestingly, changes in
pain perception following tDCS have been documented in several
experimental protocols where anodal tDCS over the DLPFC
increased the pain thresholds induced by electrical and heat
stimuli in healthy volunteers (Boggio et al., 2008; Mylius et al.,
2012).
As for the BPI scale, the fact that anodal tDCS over the
prefrontal cortex ameliorated the interference but not the
severity subscale might be accounted by the pathophysiologic
mechanisms of pain. Actually, a pain matrix was conceptualized
and includes three interacting networks (Garcia-Larrea and
Peyron, 2013). A first order nociceptive network comprises
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TABLE 2 | VAS and BPI scores (Mean ± SD) before and after sham and active tDCS.
Before sham After sham Paired t-test Before tDCS After tDCS Paired t-test
VAS mean/7days 52.1 ± 19.6 50.3 ± 19.7 P = 0.66 51.2 ± 19.2 43.1 ± 26.2 P = 0.02
VAS mean/Day 1–3 48.8 ± 22.0 51.3 ± 18.8 P = 0.56 53.1 ± 20.2 43.1 ± 26.2 P = 0.02
BPI global score 9.9 ± 3.5 9.2 ± 3.4 P = 0.19 9.2 ± 3.4 8.2 ± 3.5 P = 0.02
BPI severity subscale 4.8 ± 2.4 4.6 ± 2.1 P = 0.40 4.8 ± 2.4 4.3 ± 2.1 P = 0.15
BPI interference subscale 5.0 ± 1.5 4.6 ± 1.6 P = 0.18 4.5 ± 1.6 3.9 ± 1.6 P = 0.01
TABLE 3 | ANT results (Mean ± SD) before and after sham and active tDCS.
Before sham After sham Paired t-test Before tDCS After tDCS Paired t-test
ANT alertness 61.7 ± 60.5 58.8 ± 66.0 P = 0.78 36.5 ± 42.0 52.1 ± 36.0 P = 0.08
ANT orientation 53.7 ± 33.2 53.4 ± 27.5 P = 0.98 41.0 ± 30.5 50.2 ± 27.4 P = 0.33
ANT conflict 143.0 ± 67.9 141.8 ± 53.2 P = 0.95 143.1 ± 75.8 153.9 ± 69.0 P = 0.43
ANT mean reaction time 768.3 ± 95.0 766.1 ± 130.3 P = 0.94 725.4 ± 93.8 742.3 ± 99.7 P = 0.38
ANT accuracy 86.1 ± 21.7 90.2 ± 14.6 P = 0.43 92.4 ± 9.2 88.4 ± 15.0 P = 0.17
TABLE 4 | Neuropsychological results (Mean ± SD) before and after sham and active tDCS.
Before sham After sham t-test Before tDCS After tDCS t-test
Mean HADS total score 14.4 ± 5.9 14.5 ± 6.5 P = 0.80 14.1 ± 6.3 13.6 ± 5.8 P = 0.52
Mean HADS anxiety 8.1 ± 3.4 8.3 ± 3.9 P = 0.70 7.7 ± 3.0 7.6 ± 3.6 P = 0.90
Mean HADS depression 6.3 ± 3.0 6.2 ± 3.3 P = 0.81 6.4 ± 3.9 6.0 ± 3.3 P = 0.35
MFIS global score 48.2 ± 15.5 47.4 ± 17.7 P = 0.76 49.5 ± 14.4 49.0 ± 15.2 P = 0.42
the posterior operculoinsular area receiving spinothalamic
projections. A second order network consists of the posterior
parietal, prefrontal and anterior insular areas, and is responsible
of the transition from cortical nociception to conscious
perception. A third network is composed of the orbitofrontal,
perigenual and limbic areas, by which the pain perception can
be modified in function of expectations, emotions and beliefs.
Therefore, our results suggest that tDCS could have acted on the
second and third order networks of the pain matrix where the
prefrontal cortex majorly contributes (Garcia-Larrea and Peyron,
2013).
Effects on Attention
Concerning attention, ANT variables did not significantly change
after any of the tDCS interventions. In fact, we hypothesized that
tDCS over the DLPFC could improve attentional capacities by
modifying the sensitivity of stimulus-specific neural responses, in
a way that enhances the top-down selection type or inhibits the
bottom-up one; notably, by amplifying or inhibiting the activity
of neurons which respond, respectively, to relevant or irrelevant
stimuli (Desimone and Duncan, 1995). In accordance with our
speculation, anodal tDCS over the left DLPFC have found to
improve the attentional bias acquisition in one study (Clarke
et al., 2014), and sustained attention in another one (Nelson
et al., 2014). However, the lack of significant improvement of
ANT parameters in our study can be explained by many facts.
First, ANT is known to represent a complex task which measures
three different attentional networks and hence involves several
cortico-cortical and cortico-subcortical connections. Second, in
contrast to previous tDCS studies in healthy subjects, MS patients
are known to have a dysfunction in the attentional networks,
notably in the alerting and/or the orienting ones (Urbanek et al.,
2010; Crivelli et al., 2012; Omisade et al., 2012; Vázquez-Marrufo
et al., 2014; Ayache et al., 2015) which might have prevented
tDCS from causing any improvement. Third, our tDCS design
might not have been optimal to ameliorate ANT variables. It is
noteworthy that a lateralization in the attentional performance
exists between left and right hemispheric structures (Corbetta
and Shulman, 2002; Raz and Buhle, 2006; Lückmann et al., 2014).
In fact, the left and right hemispheres are thought to be involved
in phasic and tonic alertness, respectively (Raz and Buhle, 2006).
In this model, the right DLPFC has an executory capacity which
enables it to monitor the attentional performance and hence
regulates it accordingly, while the right inferior parietal region
seems to have a role in endogenous and exogenous alerting. In
line with this topography, one study found that anodal tDCS
over the right frontal cortex (F10 of the 10–10 EEG system of
electrodes positioning) could improve the alerting network of
attention (Coffman et al., 2012). Another study compared the
effects of anodal tDCS over different cortical targets in terms of
attentional improvement and showed significant effects following
the stimulation of the right posterior parietal cortex (PPC) but
not the left DLPFC (Roy et al., 2015). This suggests that unlike
our design, which targeted the left hemisphere, stimulation of
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TABLE 5 | Neurophysiological (EEG and PREPS) results (Mean ± SD) before and after sham and active tDCS.
Before sham After sham Paired t-test Before tDCS After tDCS Paired t-test
Theta Fpz 51.1 ± 14.6 58.9 ± 10.2 P = 0.09 53.8 ± 13.9 62.1 ± 11.1 P = 0.09
Theta Fz 53.9 ± 9.8 59.3 ± 7.9 P = 0.04 54.9 ± 15.1 62.6 ± 10.5 P = 0.09
Mean N2 latency 118.9 ± 34.8 131.7 ± 25.6 P = 0.16 138.1 ± 44.6 141.8 ± 33.2 P = 0.66
Mean P2 latency 178.0 ± 48.8 187.0 ± 36.0 P = 0.41 202.2 ± 58.5 199.6 ± 45.9 P = 0.80
Mean N2 amplitude 11.3 ± 7.6 14.1 ± 6.5 P = 0.16 12.6 ± 9.9 12.0 ± 7.4 P = 0.77
Mean P2 amplitude 10.5 ± 4.3 10.4 ± 7.6 P = 0.96 15.1 ± 10.7 13.2 ± 9.4 P = 0.57
Mean N2-P2 amplitude 21.4 ± 8.9 22.4 ± 9.2 P = 0.64 25.2 ± 9.0 23.6 ± 13.0 P = 0.50
the right fronto-parietal structures might have better effects
on attention. Fourth, our protocol consisted of performing
ANT before the first stimulation session (D1) and after the
last one (D3) of each block, but did not contain a “within-
day control” of attention. This was based on the hypothesis
that a tDCS-induced cumulative effect might result from the
repetition of the stimulation sessions. However, three consecutive
daily sessions might not be enough to induce such an effect,
and therefore a within-day control for attention would have
revealed better outcomes. Fifth, concerning the tDCS montage
adopted in this study, the anode was placed at the left DLPFC
while its reference electrode was the right supraorbital region.
We should note that the chosen reference is not neutral. In
fact the orbitofrontal cortex has an important role inemotional
and cognitive processing, including the attentional processes to
emotional stimuli. Therefore, applying a cathodal stimulation on
that region might have impacted our results.
These data altogether suggest that future studies might benefit
from comparing the effects of tDCS over different cortical
areas (e.g., left/right DLPFC and left/right PPC), prolonging the
duration of the stimulation period, adding a within-day control
for attention, and adopting a different reference site, before
drawing any conclusion.
Effects on Mood and Fatigue
As for mood changes, although there are evidence regarding the
antidepressant effects of anodal tDCS over the DLPFC (Kalu
et al., 2012; Loo et al., 2012; Berlim et al., 2013; Brunoni et al.,
2013), the lack of mood changes in our patients cohort can be
attributed to the short stimulation period adapted in this study. In
this perspective, depression studies have shown dose-dependent
effects of tDCS in mood improvement that could extend over
several weeks. Our results are supported by another study where
no improvement in mood scores has occurred following five
tDCS sessions over the left DLPFC (Saiote et al., 2014).
Concerning fatigue, we found no effects of tDCS on the MFIS
scores. A lack of improvement in fatigue following tDCS has
already been reported by two studies (Ferrucci et al., 2014; Saiote
et al., 2014).
Effects on Neurophysiological Parameters
PREPs
PREPs amplitudes were not changed following both active and
sham tDCS. Although PREPs can correlate with the subjective
pain sensation, it is commonly accepted that PREPs amplitude
reflects the integrity of the spino-thalamo-cortical tract (Casey
et al., 1996; Wu et al., 1999; Garcia-Larrea et al., 2002). In this
view, most of the neuroimaging studies have demonstrated that
MS patients with neuropathic pain had several demyelinating
lesions within the spinal cord, brainstem, and thalamus (Seixas
et al., 2014). Furthermore, PREPs amplitude is known to depend
on the attentional level toward the stimulated limb (Garcia-
Larrea et al., 2002), in this context, attentional dysfunction has
been frequently reported in MS patients. Taken together, these
disturbances might have prohibited tDCS from having any effect
on PREPs parameters in our cohort.
EEG
As for the frontal midline theta activity, their increase following
both stimulation blocks can be explained by different approaches.
In fact, anxiety improvement has previously been correlated with
the appearance of such waves following anxiolytic treatment
(Mizuki et al., 1983, 1989). In addition, an emotionally
positive state was found to be associated with theta power
in frontal midline leads (Aftanas and Golocheikine, 2001).
In this perspective, it might be possible that medical care
itself, regardless of stimulation block type, had accounted for a
subtle decrease in patients’ anxiety, despite the absence of any
significant changes in HADS scores.
Limitations
It is important to note that, in our patients’ cohort, the observed
tDCS effects could have been influenced by antiepileptic
treatments. The latter are known to inhibit long-term-
potentiation induced neuroplasticity changes by blockade
of voltage-gated ion channels (Nitsche et al., 2012). However,
in most of the studies dealing with chronic neuropathic pain,
patients commonly suffer from a severe pain which is resistant to
multiple drugs. Particularly, the available tDCS studies for central
neuropathic pain have included patients taking antiepileptics,
antidepressants, and opioid analgesics (Fregni et al., 2006; Soler
et al., 2010; Wrigley et al., 2013). Similar to our work, the
authors asked their patients to keep their routine medications
throughout the study period. Another limitation would be the
lack of functional or structural neuroimaging data in our work.
Future studies can benefit from combining imaging with tDCS
application, in order to understand the mechanisms of action of
tDCS on the studied brain networks, and to correlate the clinical
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response to gray matter and white matter pathologies (Chalah
et al., 2015). In addition, the small sample size and heterogeneity
of our MS cohort could have prohibited the emergence of any
positive effect in terms of attention, mood and fatigue. Finally,
MS-related symptoms can fluctuate during the course of the
disease; such a fluctuation should be taken into account prior to
the interpretation of any intervention results. In this context, our
study could have benefited from testing the difference between
baseline scores prior to tDCS and sham conditions. However,
we believe that our inclusion criteria (e.g., the presence of a
neuropathic pain since more than 3 months with an intensity
greater than 40 on VAS; the absence of MS relapses since at last
2 months, a stable therapy since 1 month) might have restricted
such an influence. We also controlled for the impact of some
variables on attention, pain, and fatigue; namely by restricting
the consumption of psychostimulants, and performing the
stimulation block at the same time during the day, with no
blocks occurring in summer.
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